Sarepta Therapeutics,, Inc. (SRPT)

NASDAQ

$17.50

$-0.04

(-0.24%)

Pre-Market

Sarepta Therapeutics,, Inc. (SRPT) Live Price Chart

Last updated: ⁦2026-10-20 10:44:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Sarepta Therapeutics,, Inc. (SRPT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17.50, with a market capitalization of $1.81B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.68 to $24.68. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.81B
Open	$17.54
Day's High	$181.83
Day's Low	$3.30
Previous Close	$17.73
Volume	97.00
Average Volume	3.08M
P/E Ratio	--
52-Week High	$24.68
52-Week Low	$14.68
Dividend Yield	--
Earnings Date	--

Sarepta Therapeutics,, Inc. (SRPT) Pre-Market Stock Price

Sarepta Therapeutics,, Inc. (SRPT) is trading at $17.50 in pre-market trading as of 2026-10-20 09:49:00, down 1.30% ($0.23) from the previous close of $17.73

Pre-market trading shows how investors are pricing SRPT before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Sarepta Therapeutics,, Inc. (SRPT) 7-Day Stock Price Change

Over the past seven days, Sarepta Therapeutics,, Inc. (SRPT) moved from $17.85 to $17.50, representing a decline of 1.96% ($0.35).

The stock traded between $16.37 and $18.53 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 4.14 million shares, up versus the previous seven-day period, indicating higher trading activity.

SRPT 52-Week Price Position

Position in Range: 28.2%

52W Low$14.68

52W High$24.68

SRPT is currently trading at $17.50, placing it 28.2% of the way from its 52-week low of $14.68 to its 52-week high of $24.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Sarepta Therapeutics,, Inc. (SRPT)?

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Sarepta Therapeutics,, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	835
Exchange	NASDAQ
Company Website	https://www.sarepta.com

How to Buy Sarepta Therapeutics,, Inc. (SRPT) Stock on MEXC

Eligible investors can buy real shares of Sarepta Therapeutics,, Inc. (SRPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SRPT and Place Your Order

Open the RealStocks trading page and search for SRPT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Sarepta Therapeutics,, Inc. (SRPT) stock price today?

Sarepta Therapeutics,, Inc. (SRPT) is currently trading at $ 17.50, down 1.30% ($0.23) from the previous close of $ 17.73. Intraday prices update in real time during regular trading hours.

2.Is SRPT stock going up or down today?

As of 2026-10-20 09:49:00, SRPT is trading at $ 17.50, down 1.30% ($0.23) from its previous close of $ 17.73. The stock has traded between $ 3.30 and $ 181.83 during today’s regular session. Past price movements do not guarantee future results.

3.What is SRPT pre-market price?

As of 2026-10-20 09:49:00, SRPT is trading at $ 17.50 in pre-market trading, down 1.30% ($0.23) from the previous close of $ 17.73. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SRPT after-hours price?

As of 2026-10-20 09:49:00, SRPT is trading at $ 17.55 in after-hours trading, down 1.00% ($0.18) from the regular-session close of $ 17.73. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SRPT stock trading now?

SRPT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SRPT sit relative to its 52-week high and low?

Over the past 52 weeks, SRPT has traded between a low of $ 14.68 and a high of $ 24.68. At $ 17.50, the stock is positioned 28.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Sarepta Therapeutics,, Inc. in?

Sarepta Therapeutics,, Inc. (SRPT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Sarepta Therapeutics,, Inc.'s market capitalization and where is it listed?

Sarepta Therapeutics,, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.81B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SRPT valued in terms of P/E ratio and EPS?

SRPT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.29. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Sarepta Therapeutics,, Inc. pay a dividend?

Sarepta Therapeutics,, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.